Literature DB >> 33513955

Molecular Modeling Studies on the Multistep Reactivation Process of Organophosphate-Inhibited Acetylcholinesterase and Butyrylcholinesterase.

Jakub Jończyk1, Jędrzej Kukułowicz1, Kamil Łątka1, Barbara Malawska1, Young-Sik Jung2,3, Kamil Musilek4,5, Marek Bajda1.   

Abstract

Poisoning with organophosphorus compounds used as pesticides or misused as chemical weapons remains a serious threat to human health and life. Their toxic effects result from irreversible blockade of the enzymes acetylcholinesterase and butyrylcholinesterase, which causes overstimulation of the cholinergic system and often leads to serious injury or death. Treatment of organophosphorus poisoning involves, among other strategies, the administration of oxime compounds. Oximes reactivate cholinesterases by breaking the covalent bond between the serine residue from the enzyme active site and the phosphorus atom of the organophosphorus compound. Although the general mechanism of reactivation has been known for years, the exact molecular aspects determining the efficiency and selectivity of individual oximes are still not clear. This hinders the development of new active compounds. In our research, using relatively simple and widely available molecular docking methods, we investigated the reactivation of acetyl- and butyrylcholinesterase blocked by sarin and tabun. For the selected oximes, their binding modes at each step of the reactivation process were identified. Amino acids essential for effective reactivation and those responsible for the selectivity of individual oximes against inhibited acetyl- and butyrylcholinesterase were identified. This research broadens the knowledge about cholinesterase reactivation and demonstrates the usefulness of molecular docking in the study of this process. The presented observations and methods can be used in the future to support the search for new effective reactivators.

Entities:  

Keywords:  acetylcholinesterase; butyrylcholinesterase; docking studies; molecular modeling; organophosphates; reactivation process; reactivators

Year:  2021        PMID: 33513955      PMCID: PMC7912477          DOI: 10.3390/biom11020169

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  44 in total

1.  Oxime K203: a drug candidate for the treatment of tabun intoxication.

Authors:  Lukas Gorecki; Ondrej Soukup; Tomas Kucera; David Malinak; Daniel Jun; Kamil Kuca; Kamil Musilek; Jan Korabecny
Journal:  Arch Toxicol       Date:  2018-12-18       Impact factor: 5.153

2.  Pseudo-catalytic scavenging: searching for a suitable reactivator of phosphorylated butyrylcholinesterase.

Authors:  Zrinka Kovarik; Maja Katalinić; Goran Sinko; Jiri Binder; Ondrej Holas; Young-Sik Jung; Lucie Musilova; Daniel Jun; Kamil Kuca
Journal:  Chem Biol Interact       Date:  2010-03-03       Impact factor: 5.192

3.  Phosphoryl oxime inhibition of acetylcholinesterase during oxime reactivation is prevented by edrophonium.

Authors:  C Luo; A Saxena; M Smith; G Garcia; Z Radić; P Taylor; B P Doctor
Journal:  Biochemistry       Date:  1999-08-03       Impact factor: 3.162

4.  Crystal structures of acetylcholinesterase in complex with organophosphorus compounds suggest that the acyl pocket modulates the aging reaction by precluding the formation of the trigonal bipyramidal transition state.

Authors:  Andreas Hörnberg; Anna-Karin Tunemalm; Fredrik Ekström
Journal:  Biochemistry       Date:  2007-04-03       Impact factor: 3.162

Review 5.  Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning.

Authors:  Milan Jokanović; Milos P Stojiljković
Journal:  Eur J Pharmacol       Date:  2006-10-11       Impact factor: 4.432

6.  Revealing the importance of linkers in K-series oxime reactivators for tabun-inhibited AChE using quantum chemical, docking and SMD studies.

Authors:  Shibaji Ghosh; Nellore Bhanu Chandar; Kalyanashis Jana; Bishwajit Ganguly
Journal:  J Comput Aided Mol Des       Date:  2017-06-23       Impact factor: 3.686

7.  Evaluation of oxime k203 as antidote in tabun poisoning.

Authors:  Zrinka Kovarik; Ana Lucić Vrdoljak; Suzana Berend; Maja Katalinić; Kamil Kuc; Kamil Musilek; Bozica Radić
Journal:  Arh Hig Rada Toksikol       Date:  2009-03       Impact factor: 1.948

8.  Aging of cholinesterases phosphylated by tabun proceeds through O-dealkylation.

Authors:  Eugénie Carletti; He Li; Bin Li; Fredrik Ekström; Yvain Nicolet; Mélanie Loiodice; Emilie Gillon; Marie T Froment; Oksana Lockridge; Lawrence M Schopfer; Patrick Masson; Florian Nachon
Journal:  J Am Chem Soc       Date:  2008-11-26       Impact factor: 15.419

Review 9.  Clinical features of organophosphate poisoning: A review of different classification systems and approaches.

Authors:  John Victor Peter; Thomas Isiah Sudarsan; John L Moran
Journal:  Indian J Crit Care Med       Date:  2014-11

10.  A newly developed oxime K203 is the most effective reactivator of tabun-inhibited acetylcholinesterase.

Authors:  Kamil Kuca; Kamil Musilek; Daniel Jun; Jana Zdarova-Karasova; Eugenie Nepovimova; Ondrej Soukup; Martina Hrabinova; John Mikler; Tanos C C Franca; Elaine F F Da Cunha; Alexandre A De Castro; Martin Valis; Teodorico C Ramalho
Journal:  BMC Pharmacol Toxicol       Date:  2018-02-21       Impact factor: 2.483

View more
  2 in total

1.  Broad-Spectrum Antidote Discovery by Untangling the Reactivation Mechanism of Nerve-Agent-Inhibited Acetylcholinesterase.

Authors:  Cecilia Lindgren; Nina Forsgren; Norman Hoster; Christine Akfur; Elisabet Artursson; Lotta Edvinsson; Richard Svensson; Franz Worek; Fredrik Ekström; Anna Linusson
Journal:  Chemistry       Date:  2022-06-07       Impact factor: 5.020

Review 2.  FDA-Approved Oximes and Their Significance in Medicinal Chemistry.

Authors:  Jyothi Dhuguru; Eugene Zviagin; Rachid Skouta
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.